Expression Profile as Predictor of Relapse after Adjuvant Treatment in Gastric Cancer

[1]  J. Feliu,et al.  EPO-R Expression Patterns in Resected Gastric Adenocarcinoma Followed by Adjuvant Chemoradiation Treatment , 2009, Pathology & Oncology Research.

[2]  M. Jeffers,et al.  Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false-positive or false-negative immunohistochemistry? , 2006, Journal of Clinical Pathology.

[3]  H. Yoo,et al.  Expression profiling and subtype-specific expression of stomach cancer. , 2003, Cancer research.

[4]  F. Carneiro,et al.  Mixed carcinoma of the stomach: a clinicopathological entity , 2003, Histopathology.

[5]  H. Lee,et al.  Tumour suppressor gene expression correlates with gastric cancer prognosis , 2003, The Journal of pathology.

[6]  H. Höfler,et al.  Relationship between E‐cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl‐2 expression and Ki‐67 staining in diffuse‐type gastric carcinoma , 2003, International journal of cancer.

[7]  E. Crivellato,et al.  Erythropoietin as an angiogenic factor in gastric carcinoma , 2003, Histopathology.

[8]  Aller,et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2002, The New England journal of medicine.

[9]  Li Dong Wang,et al.  Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features , 2002, BMC Cancer.

[10]  A. Xu,et al.  Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. , 2001, World journal of gastroenterology.

[11]  J C Reed,et al.  Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. , 2001, Molecular cell.

[12]  A. Dursun,et al.  Expression of c-erbB-2 Oncoprotein in Gastric Carcinoma: Correlation with Histopathologic Characteristics and Analysis of Ki-67 , 1999, Pathology & Oncology Research.

[13]  B. Geiger,et al.  Excess β‐catenin promotes accumulation of transcriptionally active p53 , 1999, The EMBO journal.

[14]  N. Vogelzang,et al.  Intrapleural administration of interleukin‐2 for the treatment of patients with malignant pleural mesothelioma , 1998, Cancer.

[15]  M. Sobrinho-Simões,et al.  Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. , 1998, Gastroenterology.

[16]  H. Allgayer,et al.  Prognostic factors in gastric cancer , 1997, The British journal of surgery.

[17]  M. Sobrinho-Simões,et al.  Prognostic factors in gastric carcinoma. , 1997, British Journal of Cancer.

[18]  P. Maslak,et al.  The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents , 1995, International journal of cancer.

[19]  D. Housman,et al.  p53 status and the efficacy of cancer therapy in vivo. , 1994, Science.

[20]  J. Hart,et al.  Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma. , 1994, Surgery.

[21]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[22]  M. Mori,et al.  Increased incidence of undifferentiated type of gastric cancer with tumor progression in 912 patients with early gastric cancer and 1245 with advanced gastric cancer , 1994, Cancer.

[23]  J. Siewert,et al.  Prognostic factors in gastric carcinoma. Results of the German gastric carcinoma study 1992 , 1993, Cancer.

[24]  W. Blot,et al.  Precancerous gastric lesions in a population at high risk of stomach cancer. , 1993, Cancer research.

[25]  A. C. Parekh,et al.  Urinary inorganic phosphorus determinations , 1972, Journal of Clinical Pathology.

[26]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.